ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients

2023-06-04 12:19:42

–

ASCO 2023

Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses.

Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death.

1685882522
#Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium